Investment Objective


Actively managed and diversified portfolio of typically 20 – 40 high quality emerging market companies diversified by geography, industry and market capitalisation.

A long-term investment approach based on the belief that superior investment returns rely on fundamental investment research, good judgement and experience.

The ability for the portfolio manager to call on the research from typically 400 research meetings a year visiting companies in their home market.

Fund Facts

Benchmark MSCI Emerging Markets Total Return Index in AUD
Stock Range 20 – 40
Individual Stock Weight 0-10%
Inception Date 22 July 2020
Fund Size $8.7m
Distribution Frequency Semi-Annual
Base Management Fee 1.23% p.a.
Performance Fee 20.5% of after-management fee performance over the Benchmark subject to a relative high-water mark
Buy/Sell Spread 0.50% / 0.50%
Currency Unhedged
APIR Code WRA4779AU
ARSN 642 392 863

Performance, Prices & Distributions


Net returns as at 31 January 2021

1 month
%

3 months
%

FYTD
%

1 year
%

3 years
% pa

5 years
% pa

10 years
% pa

Since inception (22/07/2020)
% pa

Fund +1.56 +7.37 +13.64 - - - - +13.64
Benchmark +3.66 +10.64 +15.70 - - - - +15.70
Relative Return -2.10 -3.27 -2.06 - - - - -2.06

Past performance is not a reliable indicator of future performance. The return of capital is not guaranteed.
This is a new fund. Fund inception date 22 July 2020.

Current Unit Price
Prices as at 25 February 2021

Month-end Unit Price
Prices as at 29 January 2021

Application $1.1019 $1.1421
Redemption $1.0909 $1.1307

This is a new fund. Fund inception date 22 July 2020.

Distribution Rate

Reinvestment Price

31 December 2020 $0.00 N/A

This is a new fund. Fund inception date 22 July 2020.

Portfolio Holdings

As at 31 January 2021

Company Name Sector Country Weighting
iShares MSCI India ETF* ETF India 13.4%
Techtronic Industries Co., Ltd. Industrials Hong Kong 7.5%
Taiwan Semiconductor Manufacturing Co., Ltd. Information Technology Taiwan 7.3%
Top Glove Corp Health Care Malaysia 7.3%
Samsung Electronics Co., Ltd. Information Technology South Korea 7.0%
Hartalega Holdings Bhd. Health Care Malaysia 5.4%
Sk Hynix Information Technology South Korea 4.9%
LG Household & Health Care Ltd Consumer Staples South Korea 4.4%
Mercadolibre Consumer Discretionary United States 3.9%
Hdfc Bank Financials India 3.8%
64.9%

Portfolio holdings are subject to change. *This is a new fund with an inception date 22 July 2020. Alternative exposure for the Fund until trading account in India is activated.

As at 31 January 2021

 
24% Information Technology
15% Industrials
13% Healthcare
13% India ETF
9% Consumer Staples
8% Financials
6% Communication Services
4% Consumer Discretionary
1% Materials
7% Cash
 

As at 31 January 2021

 
17% India
13% Malaysia
14% Other
16% South Korea
13% Taiwan
10% China/HK
6% Mexico
1% Thailand
1% Brazil
 

Fund Ratings

Organisation Rating / Recommendation
Zenith Investment Partners Recommended